El-Mesery Mohamed, Rudolf Franziska, Heimann Yannick, Häcker Georg, Brunner Thomas
Biochemical Pharmacology, Department Biology, University of Konstanz, Konstanz, Germany.
Collaborative Research Center TRR 353 "Death Decisions".
Cell Cycle. 2024 Nov-Dec;23(21-24):931-948. doi: 10.1080/15384101.2025.2484868. Epub 2025 Mar 27.
The large family of BCL-2 proteins plays a well-established role in the regulation of mitochondrial apoptosis pathway, and the crosstalk between death receptor signaling and mitochondrial apoptosis. Accumulating evidence suggests, however, that various BCL-2 family members are also involved in the regulation of apoptosis-unrelated necrotic forms of cell death, and even non-cell death processes. In this review, we discuss the emerging role of BCL-2 family members, and in particular BIM, in the regulation of mitochondrial dynamics, morphology and energy metabolism, and associated consequences for drug-inuced necrotic cell death.
BCL-2蛋白大家族在调节线粒体凋亡途径以及死亡受体信号传导与线粒体凋亡之间的相互作用中发挥着既定作用。然而,越来越多的证据表明,各种BCL-2家族成员也参与了与凋亡无关的坏死性细胞死亡形式的调节,甚至参与了非细胞死亡过程。在本综述中,我们讨论了BCL-2家族成员,特别是BIM,在调节线粒体动力学、形态和能量代谢方面的新作用,以及对药物诱导的坏死性细胞死亡的相关影响。